(Q43014298)

English

NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse following All

scientific article published on 14 June 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 November 2017

NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse following All (English)

1 reference

Europe PubMed Central

12 November 2017

0 references

14

1 reference

Europe PubMed Central

12 November 2017

2

object named as

Ulrike Bacher

1 reference

Europe PubMed Central

12 November 2017

15

object named as

Sergio Giralt

1 reference

Europe PubMed Central

12 November 2017

12

object named as

Julie M Vose

1 reference

Europe PubMed Central

12 November 2017

7

object named as

Issa Khouri

1 reference

Europe PubMed Central

12 November 2017

Daniel J Weisdorf

13

object named as

Daniel Weisdorf

1 reference

Europe PubMed Central

12 November 2017

Homer A Macapinlac

8

object named as

Homer A Macapinlac

1 reference

Europe PubMed Central

12 November 2017

11

object named as

Wendy Stock

1 reference

Europe PubMed Central

12 November 2017

Eduardo Olavarria

9

object named as

Eduardo Olavarria

1 reference

Europe PubMed Central

12 November 2017

3

object named as

Peter Bader

1 reference

Europe PubMed Central

12 November 2017

Sebastian Böttcher

4

object named as

Sebastian Böttcher

1 reference

Europe PubMed Central

12 November 2017

Michael J Borowitz

5

object named as

Michael J Borowitz

1 reference

Europe PubMed Central

12 November 2017

6

object named as

Peter Dreger

1 reference

Europe PubMed Central

12 November 2017

Jerald P Radich

10

object named as

Jerald Radich

1 reference

Europe PubMed Central

12 November 2017

author name string

Nicolaus Kröger

1

1 reference

Europe PubMed Central

12 November 2017

Michael R Bishop

16

1 reference

Europe PubMed Central

12 November 2017

Alan S Wayne

17

1 reference

Europe PubMed Central

12 November 2017

publication date

14 June 2010

1 reference

Europe PubMed Central

12 November 2017

Biology of Blood and Marrow Transplantation

1 reference

Europe PubMed Central

12 November 2017

16

1 reference

Europe PubMed Central

12 November 2017

1187-1211

1 reference

Europe PubMed Central

12 November 2017

9

1 reference

Europe PubMed Central

12 November 2017

The role of multiparameter flow cytometry for detection of minimal residual disease in acute myeloid leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative determination of bone marrow transplant engraftment using fluorescent polymerase chain reaction primers for human identity markers

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

International standardisation of quantitative real-time RT-PCR for BCR-ABL

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic transplantation for pediatric acute lymphoblastic leukemia: the emerging role of peritransplantation minimal residual disease/chimerism monitoring and novel chemotherapeutic, molecular, and immune approaches aimed at preventing relapse

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Minimal residual disease tests provide an independent predictor of clinical outcome in adult acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Abnormal Cytogenetics at Date of Morphologic Complete Remission Predicts Short Overall and Disease-Free Survival, and Higher Relapse Rate in Adult Acute Myeloid Leukemia: Results From Cancer and Leukemia Group B Study 8461

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Minimal residual disease monitoring in adult T-cell acute lymphoblastic leukemia: a molecular based approach using T-cell receptor G and D gene rearrangements.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of highly polymorphic DNA probes for genotypic analysis following bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

RUNX1 gene mutation in primary myelodysplastic syndrome--the mutation can be detected early at diagnosis or acquired during disease progression and is associated with poor outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of first-line imatinib interim therapy on the outcome of allogeneic stem cell transplantation in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

B-cell reconstitution after allogeneic SCT impairs minimal residual disease monitoring in children with ALL

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High WT1 expression after induction therapy predicts high risk of relapse and death in pediatric acute myeloid leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Kinetics of plasma-cell chimerism after allogeneic stem cell transplantation by highly sensitive real-time PCR based on sequence polymorphism and its value to quantify minimal residual disease in patients with multiple myeloma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biologic and clinical features

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Minimal residual disease in acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Minimal residual disease levels in bone marrow and peripheral blood are comparable in children with T cell acute lymphoblastic leukemia (ALL), but not in precursor-B-ALL

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Minimal residual disease based on patient specific Flt3-ITD and -ITT mutations in acute myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An international study to standardize the detection and quantitation of BCR-ABL transcripts from stabilized peripheral blood preparations by quantitative RT-PCR.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Leukaemia-associated immunophenotypes (LAIP) are observed in 90% of adult and childhood acute lymphoblastic leukaemia: detection in remission marrow predicts outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Wilms tumour gene 1 overexpression in bone marrow as a marker for minimal residual disease in acute myeloid leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Flow cytometry evaluation of erythroid dysplasia in patients with myelodysplastic syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of peripheral blood instead of bone marrow to monitor residual disease in children with acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of relapse by sequential monitoring of chimerism in circulating CD34+ cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The rate and kinetics of molecular response to donor leucocyte transfusions in chronic myeloid leukaemia patients treated for relapse after allogeneic bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia--results of the prospective multicenter LALA-94 trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monitoring of chimerism after allogeneic bone marrow transplantation with unmanipulated marrow by use of DNA polymorphisms

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chimerism-directed adoptive immunotherapy in prevention and treatment of post-transplant relapse of leukemia in childhood

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of Richter's transformation of chronic lymphocytic leukemia by PET/CT.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Status of minimal residual disease after induction predicts outcome in both standard and high-risk Ph-negative adult acute lymphoblastic leukaemia. The Polish Adult Leukemia Group ALL 4-2002 MRD Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A novel rapid single nucleotide polymorphism (SNP)-based method for assessment of hematopoietic chimerism after allogeneic stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multidimensional flow cytometry of marrow can differentiate leukemic from normal lymphoblasts and myeloblasts after chemotherapy and bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of mixed chimaerism in flow-sorted cell subpopulations by PCR-amplified VNTR markers after allogeneic bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Shifts in expression of immunological cell markers in relapsed acute leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detectable minimal residual disease before allogeneic hematopoietic stem cell transplantation predicts extremely poor prognosis in children with acute lymphoblastic leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Minimal residual disease detection in acute myeloid leukemia by mutant nucleophosmin (NPM1): comparison with WT1 gene expression.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High BAALC expression associates with other molecular prognostic markers, poor outcome, and a distinct gene-expression signature in cytogenetically normal patients younger than 60 years with acute myeloid leukemia: a Cancer and Leukemia Group B (CAL

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mixed hematopoietic chimerism following bone marrow transplantation for hematologic malignancies.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative analysis of chimerism after allogeneic bone marrow transplantation using immunomagnetic selection and fluorescent microsatellite PCR.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Favorable prognostic impact of NPM1 gene mutations in childhood acute myeloid leukemia, with emphasis on cytogenetically normal AML

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantification of CBFbeta/MYH11 fusion transcript by real time RT-PCR in patients with INV(16) acute myeloid leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of minimal residual disease in unselected patients with acute myeloid leukemia using multiparameter flow cytometry for definition of leukemia-associated immunophenotypes and determination of their frequencies in normal bone marrow.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Computerised tomography in the staging of Hodgkin's disease and non-Hodgkin's lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mixed hematopoietic chimerism after allogeneic transplantation with lymphocyte-depleted bone marrow is not associated with a higher incidence of relapse

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Minimal residual disease (MRD) monitoring using rearrangement of T-cell receptor and immunoglobulin H gene in the treatment of adult acute lymphoblastic leukemia patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mixed chimerism after allogeneic bone marrow transplantation for leukemias

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Minimal residual disease monitoring after allogeneic transplantation may help to individualize post-transplant therapeutic strategies in acute myeloid malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative assessment of WT1 gene expression after allogeneic stem cell transplantation is a useful tool for monitoring minimal residual disease in acute myeloid leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A limited antibody panel can distinguish B-precursor acute lymphoblastic leukemia from normal B precursors with four color flow cytometry: implications for residual disease detection

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imatinib compared with chemotherapy as front-line treatment of elderly patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL)

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytogenetic analysis of chimerism and leukemia relapse in chronic myelogenous leukemia patients after T cell-depleted bone marrow transplantation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

BIOMED-1 concerted action report: flow cytometric immunophenotyping of precursor B-ALL with standardized triple-stainings

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analyses of minimal residual disease based on Flt3 mutations in allogeneic peripheral blood stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential expression of WT1 gene product in non-Hodgkin lymphomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of minimal residual disease quantification by real-time reverse transcriptase polymerase chain reaction in patients with core binding factor leukemias

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of partial tandem duplications of the MLL gene in adult patients 16 to 60 years old with acute myeloid leukemia and normal cytogenetics: a study of the Acute Myeloid Leukemia Study Group Ulm.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular methods used for detection of minimal residual disease following hematopoietic stem cell transplantation in myeloid disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Marrow transplants from unrelated donors for treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multilineage hematopoietic engraftment after allogeneic peripheral blood stem cell transplantation without conditioning in SCID patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: report of the BIOMED-1 CONCERTED ACTION: inv

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Screening for MLL tandem duplication in 387 unselected patients with AML identify a prognostically unfavorable subset of AML

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Minimal residual disease status before allogeneic bone marrow transplantation is an important determinant of successful outcome for children and adolescents with acute lymphoblastic leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk assessment by monitoring expression levels of partial tandem duplications in the MLL gene in acute myeloid leukemia during therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Significant correlation between the degree of WT1 expression and the International Prognostic Scoring System Score in patients with myelodysplastic syndromes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical applications of PET in oncology

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: correlations with acute graft-versus-host disease and relapse.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of residual disease in pediatric B-cell precursor acute lymphoblastic leukemia by comparative phenotype mapping: method and significance

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

WT1 in acute leukemia, chronic myelogenous leukemia and myelodysplastic syndrome: therapeutic potential of WT1 targeted therapies

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic implications of Wilms' tumor gene (WT1) expression in patients with de novo acute myeloid leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Standardization of flow cytometric minimal residual disease evaluation in acute lymphoblastic leukemia: Multicentric assessment is feasible.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Humoral immune responses against Wilms tumor gene WT1 product in patients with hematopoietic malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Integrated PET/CT: current applications and future directions

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical implications of minimal residual disease monitoring for stem cell transplantation after reduced intensity and nonmyeloablative conditioning

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Minimal residual disease levels assessed by NPM1 mutation-specific RQ-PCR provide important prognostic information in AML.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of Philadelphia chromosome-positive acute lymphoblastic leukemia by polymerase chain reaction: possible eradication of minimal residual disease by marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

FLT3 internal tandem duplication mutations in adult acute myeloid leukaemia define a high-risk group

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ALL-1 tandem duplication in acute myeloid leukemia with a normal karyotype involves homologous recombination between Alu elements.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of lineage-specific chimaerism in patients with acute leukaemia and myelodysplastic syndrome after allogeneic stem cell transplantation before and after relapse

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Minimal residula disease status as a predictor of relapse after allogenic bone marrow transplantation for children with acute lymphoblastic leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mixed chimerism of erythro- and megakaryopoiesis following allogeneic bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Wilms' tumour gene 1 (WT1) in human neoplasia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mixed T-lymphoid chimerism after allogeneic bone marrow transplantation for hematologic malignancies of children is not correlated with relapse

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Bl

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early molecular response to posttransplantation imatinib determines outcome in MRD+ Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL).

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mutations of AML1 are common in therapy-related myelodysplasia following therapy with alkylating agents and are significantly associated with deletion or loss of chromosome arm 7q and with subsequent leukemic transformation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Engraftment and chimerism, particularly of T- and B-cells, in children undergoing allogeneic bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The significance of graft-versus-host disease and pretransplantation minimal residual disease status to outcome after allogeneic stem cell transplantation in patients with acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determination of relapse risk based on assessment of minimal residual disease during complete remission by multiparameter flow cytometry in unselected patients with acute myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination of intensive chemotherapy and imatinib can rapidly induce high-quality complete remission for a majority of patients with newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevated levels of WT1 transcripts in bone marrow harvests are associated with a high relapse risk in patients autografted for acute myeloid leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Minimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALL.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: the Paris-Robert Debré experience.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcome prediction by immunophenotypic minimal residual disease detection in adult T-cell acute lymphoblastic leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Feasibility study of preemptive withdrawal of immunosuppression based on chimerism testing in children undergoing myeloablative allogeneic transplantation for hematologic malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Minimal residual disease detection after allogeneic stem cell transplantation is correlated to relapse in patients with acute lymphoblastic leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A review of the Wilms' tumor 1 gene (WT1) and its role in hematopoiesis and leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relapse after bone marrow transplantation: evidence for distinct immunological mechanisms between adult and paediatric populations

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of chimerism within specific leukocyte subsets for detection of residual or recurrent leukemia in pediatric patients after allogeneic stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Staging non-Hodgkin lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mixed hematopoietic chimerism after allogeneic bone marrow transplantation: the impact of quantitative PCR analysis for prediction of relapse and graft rejection in children

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chimeric BCR-abl messenger RNA as a marker for minimal residual disease in patients transplanted for Philadelphia chromosome-positive acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New definition of remission in childhood acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chimerism status is a useful predictor of relapse after allogeneic stem cell transplantation for acute leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular detection of minimal residual disease is associated with early relapse in adult acute lymphoblastic leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serial quantification of lymphoid and myeloid mixed chimerism using multiplex PCR amplification of short tandem repeat-markers predicts graft rejection and relapse, respectively, after allogeneic transplantation of CD34+ selected cells from peripher

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Minimal residual disease in leukaemia patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of bcr-abl transcripts in Philadelphia chromosome-positive acute lymphoblastic leukemia after marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of diagnostic and relapse flow cytometry phenotypes in childhood acute lymphoblastic leukemia: implications for residual disease detection: a report from the children's oncology group

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multiple myeloma: appearance at MR imaging

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic impact of RT-PCR-based quantification of WT1 gene expression during MRD monitoring of acute myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monitoring minimal residual disease in acute myeloid leukaemia with NPM1 mutations by quantitative PCR: clonal evolution is a limiting factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multidetector CT of the spine in multiple myeloma: comparison with MR imaging and radiography

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Standardization of WT1 mRNA quantitation for minimal residual disease monitoring in childhood AML and implications of WT1 gene mutations: a European multicenter study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic relevance of FLT3-TKD mutations in AML: the combination matters--an analysis of 3082 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Revised response criteria for malignant lymphoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Real-time quantitative PCR detection of WT1 gene expression in children with AML: prognostic significance, correlation with disease status and residual disease detection by flow cytometry

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The unusual origin of the polymerase chain reaction

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

NPM1 mutations in myelodysplastic syndromes and acute myeloid leukemia with normal karyotype

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chimerism after allogeneic hematopoietic cell transplantation in childhood acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of DNA restriction fragment length polymorphisms to document marrow engraftment and mixed hematopoietic chimerism following bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High WT1 gene expression before haematopoietic stem cell transplant in children with acute myeloid leukaemia predicts poor event-free survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: the Geneva experience.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determination of minimal residual disease in leukaemia patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stability of leukemia-associated aberrant immunophenotypes in patients with acute myeloid leukemia between diagnosis and relapse: comparison with cytomorphologic, cytogenetic, and molecular genetic findings

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of CBFbeta/MYH11 fusion transcripts in patients with inv(16) acute myeloid leukemia after allogeneic bone marrow or peripheral blood progenitor cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunoglobulin and T-cell receptor gene rearrangements as PCR-based targets are stable markers for monitoring minimal residual disease in acute lymphoblastic leukemia after stem cell transplantation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MRD detection in acute lymphoblastic leukemia patients using Ig/TCR gene rearrangements as targets for real-time quantitative PCR

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A tumor suppressor and oncogene: the WT1 story.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

FLT3 tyrosine kinase domain mutations are biologically distinct from and have a significantly more favorable prognosis than FLT3 internal tandem duplications in patients with acute myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of a set of seven genes for the monitoring of minimal residual disease in pediatric acute myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acquisition of FLT3 or N-ras mutations is frequently associated with progression of myelodysplastic syndrome to acute myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Flow cytometric analysis of aberrant antigen expression of blasts using CD45 blast gating for minimal residual disease in acute leukemia and high-risk myelodysplastic syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of relapse in pediatric patients with acute leukemias and MDS after allogeneic SCT by early immunotherapy initiated on the basis of increasing mixed chimerism: a single center experience of 12 children

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Minimal residual disease studies by flow cytometry in acute leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

FLT3 length mutations as marker for follow-up studies in acute myeloid leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aberrant overexpression of the Wilms tumor gene (WT1) in human leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clearance of minimal residual disease after allogeneic stem cell transplantation and the prediction of the clinical outcome of adult patients with high-risk acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantification of donor and recipient hemopoietic cells by real-time PCR of single nucleotide polymorphisms

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of immunomodulatory treatment based on conventional and lineage-specific chimerism analysis in patients with myeloid malignancies after myeloablative allogeneic hematopoietic cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of complete disease remission in acute myeloid leukemia: a prospective study based on cytomorphology, interphase fluorescence in situ hybridization, and immunophenotyping during follow-up in patients with acute myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early Response Assessment Using 3'-Deoxy-3'-[18F]Fluorothymidine-Positron Emission Tomography in High-Grade Non-Hodgkin's Lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia: a phase II study by the Japan Adult Leukemia Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Flow cytometric follow-up of minimal residual disease in bone marrow gives prognostic information in children with acute lymphoblastic leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of PET in lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

WT1 gene expression: an excellent tool for monitoring minimal residual disease in 70% of acute myeloid leukaemia patients - results from a single-centre study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of minimal residual disease (MRD) after bone marrow transplantation (BMT) by multi-parameter flow cytometry (MPFC).

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantification of residual disease in chronic myelogenous leukemia patients on interferon-alpha therapy by competitive polymerase chain reaction

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

BIOMED-1 Concerted Action report: Flow cytometric characterization of CD7+ cell subsets in normal bone marrow as a basis for the diagnosis and follow-up of T cell acute lymphoblastic leukemia (T-ALL)

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical value of immunological monitoring of minimal residual disease in acute lymphoblastic leukaemia after allogeneic transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

FISH analysis of native smears from bone marrow and blood for the monitoring of chimerism and clonal markers after stem cell transplantation in children.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Screening and monitoring of MPL W515L mutation with real-time PCR in patients with myelofibrosis undergoing allogeneic-SCT

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New score predicting for prognosis in PML-RARA+, AML1-ETO+, or CBFBMYH11+ acute myeloid leukemia based on quantification of fusion transcripts.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of FLT3 internal tandem duplication and tyrosine kinase domain mutations for acute myeloid leukemia: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid quantification of mixed chimerism using multiplex amplification of short tandem repeat markers and fluorescence detection

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of chimerism after bone marrow transplantation using specific oligonucleotide probes

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of mixed chimerism and leukemic relapse after allogeneic bone marrow transplantation in subpopulations of leucocytes by fluorescent in situ hybridization in combination with the simultaneous immunophenotypic analysis of interphase cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Wilms' tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of real-time quantitative PCR (RQ-PCR) in AML with t(8;21).

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prompt initiation of immunotherapy in children with an increasing number of autologous cells after allogeneic HCT can induce complete donor-type chimerism: a report of 14 children

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative real-time RT-PCR analysis of PML-RAR alpha mRNA in acute promyelocytic leukemia: assessment of prognostic significance in adult patients from intergroup protocol 0129.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Wilms tumor gene (WT1) expression as a panleukemic marker

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL).

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monitoring of the JAK2-V617F mutation by highly sensitive quantitative real-time PCR after allogeneic stem cell transplantation in patients with myelofibrosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

WT1 as a universal marker for minimal residual disease detection and quantification in myeloid leukemias and in myelodysplastic syndrome.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful rapid discontinuation of immunosuppressive therapy at molecular relapse after allogeneic bone marrow transplantation in a pediatric patient with myelodysplastic syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular relapse in adult standard-risk ALL patients detected by prospective MRD monitoring during and after maintenance treatment: data from the GMALL 06/99 and 07/03 trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Red blood cell phenotyping is a sensitive technique for monitoring chronic myeloid leukaemia patients after T-cell-depleted bone marrow transplantation and after donor leucocyte infusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The impact of cell heterogeneity and immunophenotypic changes on monitoring minimal residual disease in acute myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative assessment of minimal residual disease in acute myeloid leukemia carrying nucleophosmin (NPM1) gene mutations.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Flow cytometry with anti HLA-antibodies: a simple but highly sensitive method for monitoring chimerism and minimal residual disease after HLA-mismatched stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lack of clinical utility of minimal residual disease detection in allogeneic stem cell recipients with childhood acute lymphoblastic leukemia: multi-institutional collaborative study in Japan

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sequence polymorphism systems for quantitative real-time polymerase chain reaction to characterize hematopoietic chimerism-high informativity and sensitivity as well as excellent reproducibility and precision of measurement

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[DNA polymorphisms as implant markers in allogeneic bone marrow transplantation. Preliminary evaluation]

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Real-time quantitative Y chromosome-specific PCR (QYCS-PCR) for monitoring hematopoietic chimerism after sex-mismatched allogeneic stem cell transplantation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnostic pathways in acute leukemias: a proposal for a multimodal approach

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical significance of residual disease during treatment in childhood acute myeloid leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Description of an efficient and highly informative method for the evaluation of hematopoietic chimerism following allogeneic bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New treatment strategies in childhood acute lymphoblastic leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

WT1 and GATA1 expression in myelodysplastic syndrome and acute leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative monitoring of NPM1 mutations provides a valid minimal residual disease parameter following allogeneic stem cell transplantation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The radiological demonstration of osseous metastases. Experimental observations

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

AML with 11q23/MLL abnormalities as defined by the WHO classification: incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessing hematopoietic chimerism after allogeneic stem cell transplantation by multiplexed SNP genotyping using microarrays and quantitative analysis of SNP alleles.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical implications of minimal residual disease monitoring by quantitative polymerase chain reaction in acute myeloid leukemia patients bearing nucleophosmin (NPM1) mutations

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug-induced immunophenotypic modulation in childhood ALL: implications for minimal residual disease detection.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunological detection of blast cell subpopulations in acute myeloblastic leukemia at diagnosis: implications for minimal residual disease studies.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chimerism and minimal residual disease monitoring after reduced intensity conditioning (RIC) allogeneic transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chimaerism following allogeneic bone marrow transplantation: detection of residual host cells using the polymerase chain reaction

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dynamics of lineage-restricted mixed chimerism following sex-mismatched allogeneic bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by real-time quantitative polymerase chain reaction

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of mixed chimerism by in vitro amplification of dinucleotide repeat sequences using the polymerase chain reaction

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The extent of minimal residual disease reduction after the first 4-week imatinib therapy determines outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monitoring of residual disease and guided donor leucocyte infusion after allogeneic bone marrow transplantation by chimaerism analysis with short tandem repeats

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PET/CT for therapy response assessment in lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy?

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of mixed chimerism in patients with chronic myeloid leukemia transplanted with T-cell-depleted bone marrow: involvement of different hematologic lineages before and after relapse

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natural history of mixed chimerism after bone marrow transplantation with CD6-depleted allogeneic marrow: a stable equilibrium

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Minimal residual disease-based role of imatinib as a first-line interim therapy prior to allogeneic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Polymerase chain reaction-based detection of minimal residual disease in acute lymphoblastic leukemia predicts relapse after allogeneic BMT

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparative study of molecular mutations in 381 patients with myelodysplastic syndrome and in 4130 patients with acute myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of metaphase-fluorescence in situ hybridization in follow-up of patients with acute myeloid leukemia in remission

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stability and prognostic influence of FLT3 mutations in paired initial and relapsed AML samples

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chimerism analysis within 6 months of allogeneic stem cell transplantation predicts relapse in acute myeloid leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytogenetic analysis in human bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunophenotyping investigation of minimal residual disease is a useful approach for predicting relapse in acute myeloid leukemia patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: the Tuebingen experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance and modalities of flow cytometric minimal residual disease detection in childhood acute lymphoblastic leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early detection of relapse by hypermetaphase fluorescence in situ hybridization after allogeneic bone marrow transplantation for chronic myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

WT1 gene expression: useful marker for minimal residual disease in childhood myelodysplastic syndromes and juvenile myelo-monocytic leukemia?

1 reference

https://pubmed.ncbi.nlm.nih.gov/20558311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.BBMT.2010.06.008

1 reference

Europe PubMed Central

12 November 2017

0 references

1 reference

Europe PubMed Central

12 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43014298&oldid=1857502706"